Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 61.00 7,884 08:00:06
Bid Price Offer Price High Price Low Price Open Price
60.00 62.00 62.00 61.00 61.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 105.57 -22.57 -5.26 409
Last Trade Time Trade Type Trade Size Trade Price Currency
10:50:02 O 1,286 61.70 GBX

Benchmark (BMK) Latest News

More Benchmark News
Benchmark Investors    Benchmark Takeover Rumours

Benchmark (BMK) Discussions and Chat

Benchmark Forums and Chat

Date Time Title Posts
11/4/202118:49SALMON prices 30 year high and CAT VACCINES are Go-Go564
22/5/201821:09Benchmark Holdings Plc405

Add a New Thread

Benchmark (BMK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Benchmark trades in real-time

Benchmark (BMK) Top Chat Posts

Benchmark Daily Update: Benchmark Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BMK. The last closing price for Benchmark was 61p.
Benchmark Holdings Plc has a 4 week average price of 54.50p and a 12 week average price of 54.50p.
The 1 year high share price is 67p while the 1 year low share price is currently 29p.
There are currently 670,075,556 shares in issue and the average daily traded volume is 932,497 shares. The market capitalisation of Benchmark Holdings Plc is £408,746,089.16.
hedgehog 100: 25/02/2021 07:00 UK Regulatory (RNS & others) OTAQ PLC Non-Executive Director Appointment OTAQ, the marine technology products and solutions group for the global aquaculture and offshore oil and gas industries, is pleased to announce that Malcolm Pye will join the Board of OTAQ as a Non-Executive Director with immediate effect. Malcolm founded, and from 1999 to 2019 was Chief Executive of, Benchmark Holdings plc ("Benchmark"), the world's leading aquaculture health, nutrition and genetics business. Malcolm has over 35 years' experience in international agribusiness through his various roles at Hillsdown Holdings (then HMTF Group), and through building Benchmark from the initial start-up into a major international aquaculture technology business serving the global salmon, shrimp, tilapia and farmed fish industries. Malcolm focused Benchmark's activities on animal health, breeding and genetics, advanced nutrition and knowledge/technology delivery and led the flotation of Benchmark in 2013, maintaining a lead role in investor engagement. Prior to his founding role at Benchmark, Malcolm gained wide experience in the food sector from his various senior management positions within Hillsdown Holdings, operating in animal breeding, poultry production, feed milling and veterinary services. During this time, he developed extensive experience in breeding and genetics, food production/technology, sales (including account lead responsibilities within the UK / international retail sector with a range of bluechip companies including M&S, Tesco and McDonalds) and strategic M&A as well as holding a main board position within the Group. Malcolm's work with Hillsdown Holdings in the early to mid-1990's influenced a career-long focus on sustainable food production which formed the basis and inspiration for the creation of Benchmark Holdings. Alex Hambro, Non-Executive Chairman, commented: "We are really delighted to welcome Malcolm to the Board of OTAQ. Malcolm's experience in, and knowledge of, the global aquaculture industry is unparalleled, and will be of huge benefit to OTAQ as it develops and commercialises additional sustainable technologies and services for the aquaculture farming and producing communities. Our core SealFence acoustic deterrence system has significant opportunities for growth in geographies where Malcolm has built strong long-term relationships. Furthermore, his knowledge of additional farmed species other than salmon will be extremely helpful as we expand our range of products ." Aside from the information set out in the announcement above, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.
tomps2: Benchmark (BMK) FY20 analyst presentation Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts. Video: Https:// Podcast: Https://
edmonda: Benchmark Holdings plc transformed operations during FY20 against the challenging macro conditions brought about by Covid-19, completing a fundamental restructuring via nine disposals in a 12-month period. The latter raising up to £44m, with the closure of non-core or loss-making activities allowing a refocus of the business on aquaculture and a rebasing of the cost structure. Consequently, BMK has reinforced its financial position, boosted liquidity by £50m, and appears very well positioned to execute its growth strategy to achieve commercial returns. This leads us to upgrade our FY 21/22 AEBITDA forecasts and to expect a net profit in FY23. The Group is uniquely positioned to build selectively on its leading market positions in aquaculture, notably in developing innovative and sustainable products, diversifying its product range, coupled with a strong focus on profitability and from a position of improved balance sheet strength. We also raise our retained value per share from 63p to 72p on our updated forecasts. While the shares have performed well on the back of successful disposals, those gains look fully justified.
edmonda: Management at Benchmark Holdings are doing as they promised: the disposals program is nearly complete, raising £44m which boosts financial strength. The launch of CleanTreat® + BMK08 to combat sea lice is on track. Equity Development keeps its fair value at 63p/share, read new research note here:
36jay: Massive update.Fire work soon.
edmonda: #BMK Genetics division was resilient, ongoing restructuring and cost containment a priority, DCF valuation of BMK is £421m or 63 pence per share
edmonda: Latest note on BMK and how they're coping with COVID-19 is here:
edmonda: after the successful raise of £43m and Q1 result, new research is out with increased sales and EBITDA forecasts. Analyst's fair value rises to £479m, or 72p / share, with product launches and disposals to look forward to. Click here for free access to note:
btfd497: I debated it for a while but sold up as I wanted to free funds for Beyond Meat (BYND) which is gaining massive traction due to the vegan movement + the burgers they make are very tasty! Will keep an eye on BMK as I do think at some point it will go up v quickly.
murdo mcsponge: The Norwegians like to think they know a lot about Aquaculture. The fact that this outfit has picked up a 10%+ interest, which when added to the other Norwegian Company's holding of,I think circa 30%, makes an impressive Norwegian interestin BMk. IMHO it bodes well for future growth in BMKK and its share price.
Benchmark share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210415 10:43:26